Literature DB >> 6605716

Effect of inoculum size on Haemophilus influenzae type b susceptibility to new and conventional antibiotics.

C Laferriere, M I Marks, D F Welch.   

Abstract

Thirty-three Haemophilus influenzae type b isolates, including beta-lactamase acetyltransferase-positive strains, were tested by microtiter broth dilution for susceptibility to eight beta-lactam compounds and chloramphenicol. All antibiotics except ampicillin and chloramphenicol were highly bactericidal against all isolates at an inoculum of 10(5) CFU/ml. However, at an inoculum of 10(5) CFU/ml, the minimal bactericidal concentrations of all drugs except ceftriaxone were above levels usually achievable in cerebrospinal fluid. Results of time-kill studies confirmed this inoculum effect. In vivo studies are needed to test the clinical impact of these observations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605716      PMCID: PMC185154          DOI: 10.1128/AAC.24.2.287

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

3.  Effect of ampicillin and chloramphenicol against Haemophilus influenzae.

Authors:  W E Feldman
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

4.  A comparison of chloramphenicol and ampicillin as bactericidal agents for Haemophilus influenzae type B.

Authors:  D C Turk
Journal:  J Med Microbiol       Date:  1977-02       Impact factor: 2.472

5.  Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.

Authors:  P Simard; M G Bergeron
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

6.  Susceptibility of Haemophilus influenzae type b to cefaclor and influence of inoculum size.

Authors:  R M Levin; P H Azimi; M G Dunphy
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

7.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

8.  Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases.

Authors:  M Cadoz; F Denis; H Félix; I Diop Mar
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

9.  Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.

Authors:  R R Bulger; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

10.  Relation of concentrations of Haemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis.

Authors:  W E Feldman; C M Ginsburg; G H McCracken; D Allen; P Ahmann; J Graham; L Graham
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

View more
  9 in total

1.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

2.  Bacterial counts in cerebrospinal fluid of children with meningitis.

Authors:  E Bingen; N Lambert-Zechovsky; P Mariani-Kurkdjian; C Doit; Y Aujard; F Fournerie; H Mathieu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

Review 3.  Mechanisms of beta-lactam resistance in Haemophilus influenzae.

Authors:  L Gutmann; R Williamson; E Collatz; J F Acar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 4.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

5.  Cerebrospinal fluid penetration of amikacin in children with community-acquired bacterial meningitis.

Authors:  J L Gaillard; C Silly; A Le Masne; B Mahut; F Lacaille; G Cheron; V Abadie; P Hubert; V Matha; C Coustere
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b.

Authors:  R C Gordon; R Wofford-McQueen; K Shu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 7.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

8.  Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature.

Authors:  D Greenberg; A D Siefkin; M A Velji; P D Hoeprich
Journal:  Tex Heart Inst J       Date:  1986-09

Review 9.  Bacterial meningitis in infants and children.

Authors:  M I Marks
Journal:  Infection       Date:  1984       Impact factor: 3.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.